156 related articles for article (PubMed ID: 33936868)
1. Clinicopathological Features of Craniopharyngioma: A 15-Year Study From a Tertiary Care Center in Pakistan.
Haroon S; Afzal A; Zia S; Ali SJ; Zia F; Shamail F; Irfan M; Hashmi AA
Cureus; 2021 Mar; 13(3):e14153. PubMed ID: 33936868
[TBL] [Abstract][Full Text] [Related]
2. Papillary craniopharyngioma: A clinicopathologic study of a rare entity from a major tertiary care center in Pakistan.
Tariq MU; Din NU; Ahmad Z; Memon W
Neurol India; 2017; 65(3):570-576. PubMed ID: 28488624
[TBL] [Abstract][Full Text] [Related]
3. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
Pascual JM; Prieto R; Barrios L
J Neurosurg; 2018 Oct; 131(3):949-963. PubMed ID: 30497204
[TBL] [Abstract][Full Text] [Related]
4. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
Esheba GE; Hassan AA
J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Guo Y; Pei L; Li Y; Li C; Gui S; Ni M; Liu P; Zhang Y; Zhong L
Front Endocrinol (Lausanne); 2023; 14():1180591. PubMed ID: 37324266
[TBL] [Abstract][Full Text] [Related]
6. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
[TBL] [Abstract][Full Text] [Related]
7. Papillary craniopharyngioma: a clinicopathological study of 48 cases.
Crotty TB; Scheithauer BW; Young WF; Davis DH; Shaw EG; Miller GM; Burger PC
J Neurosurg; 1995 Aug; 83(2):206-14. PubMed ID: 7616262
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas.
Feng Y; Ni M; Wang YG; Zhong LY
Exp Ther Med; 2019 Jan; 17(1):51-56. PubMed ID: 30651764
[TBL] [Abstract][Full Text] [Related]
9. Craniopharyngioma involving the anterior, middle, and posterior cranial fossa in adults: A case report.
Tian B; Li M; Du X; Zhou H; Zhou K; Li S
Front Neurol; 2023; 14():1098600. PubMed ID: 36779068
[TBL] [Abstract][Full Text] [Related]
10. Pediatric craniopharyngioma: a 20-year study on epidemiological features, clinical presentation, and survival outcomes in a tertiary care center from LMIC.
Memon F; Humayun KN; Riaz Q; Arif M; Huda NU; Laghari AA; Hilal K; Mushtaq N
Childs Nerv Syst; 2024 Feb; 40(2):427-434. PubMed ID: 37837454
[TBL] [Abstract][Full Text] [Related]
11. A Rare Case of Adamantinomatous Craniopharyngioma in an Adult.
Carpenter EA; Christie O; Fuller C; Mirchia K
Cureus; 2022 Oct; 14(10):e30000. PubMed ID: 36381754
[TBL] [Abstract][Full Text] [Related]
12. Craniopharyngioma: a clinicopathological study of 141 cases.
Tavangar SM; Larijani B; Mahta A; Hosseini SM; Mehrazine M; Bandarian F
Endocr Pathol; 2004; 15(4):339-44. PubMed ID: 15681858
[TBL] [Abstract][Full Text] [Related]
13. Outcome of Surgical Resection of Craniopharyngioma:Single Center 12 Years' Experience.
Bishokarma S; Shrestha S; Ranabhat K; Koirala S; Shrestha D; Panth R; Gongal DN
Kathmandu Univ Med J (KUMJ); 2018 Oct.-Dec.; 16(64):328-332. PubMed ID: 31729348
[TBL] [Abstract][Full Text] [Related]
14. Comparison of central diabetes insipidus (antidiuretic hormone deficiency) and stalk effect in patients with adamantinomatous and papillary craniopharyngioma.
Feng Y; Zhong L
Acta Neurol Belg; 2024 Apr; ():. PubMed ID: 38669000
[TBL] [Abstract][Full Text] [Related]
15. Association of histological subtype with risk of recurrence in craniopharyngioma patients: a systematic review and meta-analysis.
Wu J; Wu X; Yang YQ; Ding H; Yang L; Bao YY; Zhou L; Yang CX; Hong T
Neurosurg Rev; 2022 Feb; 45(1):139-150. PubMed ID: 34159471
[TBL] [Abstract][Full Text] [Related]
16. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC
J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561
[TBL] [Abstract][Full Text] [Related]
17. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma.
Coy S; Rashid R; Lin JR; Du Z; Donson AM; Hankinson TC; Foreman NK; Manley PE; Kieran MW; Reardon DA; Sorger PK; Santagata S
Neuro Oncol; 2018 Jul; 20(8):1101-1112. PubMed ID: 29509940
[TBL] [Abstract][Full Text] [Related]
19. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
[TBL] [Abstract][Full Text] [Related]
20. Craniopharyngioma in the Elderly: A Multicenter and Nationwide Study in Spain.
Iglesias P; Nocete I; Moure Rodríguez MD; Venegas-Moreno E; Ares J; Biagetti B; Rodríguez Berrocal V; Guerrero-Pérez F; Vicente A; Villar-Taibo R; Cordido F; Paja M; Glerean M; González Rivera N; Dios Fuentes E; Blanco C; Alvaréz-Escolá C; Martín T; Webb SM; Bernabéu I; Villabona C; Soto-Moreno A; Gaztambide S; Díez JJ
Neuroendocrinology; 2021; 111(10):925-936. PubMed ID: 33040060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
